GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SBMDY) » Definitions » Cyclically Adjusted PB Ratio

Stratec SE (Stratec SE) Cyclically Adjusted PB Ratio : (As of May. 22, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Stratec SE Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Stratec SE Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Stratec SE's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Cyclically Adjusted PB Ratio Chart

Stratec SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.05 11.41 11.34 5.77 2.94

Stratec SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.27 4.24 2.89 2.94 2.54

Competitive Comparison of Stratec SE's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Stratec SE's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Stratec SE's Cyclically Adjusted PB Ratio falls into.



Stratec SE Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Stratec SE's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Stratec SE's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.985/125.0381*125.0381
=6.985

Current CPI (Mar. 2024) = 125.0381.

Stratec SE Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.851 99.543 4.837
201409 3.868 99.823 4.845
201412 3.908 99.543 4.909
201503 3.687 99.717 4.623
201506 3.740 100.417 4.657
201509 3.908 100.417 4.866
201512 3.964 99.717 4.971
201603 0.000 100.017 0.000
201606 4.082 100.717 5.068
201609 4.164 101.017 5.154
201612 4.221 101.217 5.214
201703 4.447 101.417 5.483
201706 4.444 102.117 5.441
201709 4.962 102.717 6.040
201712 5.237 102.617 6.381
201803 5.375 102.917 6.530
201806 4.670 104.017 5.614
201809 4.821 104.718 5.757
201812 4.854 104.217 5.824
201903 4.854 104.217 5.824
201906 4.706 105.718 5.566
201909 4.661 106.018 5.497
201912 4.953 105.818 5.853
202003 4.883 105.718 5.775
202006 4.967 106.618 5.825
202009 5.350 105.818 6.322
202012 5.885 105.518 6.974
202103 6.103 107.518 7.097
202106 6.384 108.486 7.358
202109 6.587 109.435 7.526
202112 6.518 110.384 7.383
202203 6.717 113.968 7.369
202206 6.058 115.760 6.544
202209 5.956 118.818 6.268
202212 6.687 119.345 7.006
202303 6.907 122.402 7.056
202306 6.758 123.140 6.862
202309 6.757 124.195 6.803
202312 7.133 123.773 7.206
202403 6.985 125.038 6.985

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Stratec SE  (OTCPK:SBMDY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Stratec SE Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Stratec SE's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (Stratec SE) Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus